The effect of lenvatinib in combination with chemotherapy plus immune checkpoint inhibitors on tumor microenvironments in the mouse syngeneic tumor model

被引：0
|
作者：
Kato, Yu
Ozawa, Yoichi
Adachi, Keito
Kume, Masahiko
Adachi, Yusuke
Narita, Yudai
Kuronishi, Megumi
Matsui, Junji
Yokoi, Akira
Funahashi, Yasuhiro
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5124
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome
    Ring, Brian Z.
    Cronister, Catherine T.
    Ring, Huijun Z.
    Ross, Douglas T.
    Seitz, Robert S.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [42] Anti-tumor Immunity and Improved Survival with Combination of Immune Checkpoint Blockade and Local Chemotherapy
    Green, J.
    Rudensky, A.
    Ariyan, C. E.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S113 - S113
  • [43] Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments
    Zabransky, Daniel J.
    Danilova, Ludmila
    Leatherman, James M.
    Lopez-Vidal, Tamara Y.
    Sanchez, Jessica
    Charmsaz, Soren
    Gross, Nicole E.
    Shin, Sarah
    Yuan, Xuan
    Hernandez, Alexei
    Yang, Hongqui
    Xavier, Stephanie
    Shu, Daniel
    Saeed, Ali
    Munjal, Kabeer
    Kamdar, Zeal
    Kagohara, Luciane T.
    Jaffee, Elizabeth M.
    Yarchoan, Mark
    Ho, Won Jin
    HEPATOLOGY, 2023, 77 (05) : 1566 - 1579
  • [44] Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma
    David Tougeron
    Christophe Louvet
    Jérôme Desramé
    Ludovic Evesque
    Antoine Angelergues
    Aurélien Carnot
    Gilles Breysacher
    Aziz Zaanan
    Nicolas Etchepare
    May Mabro
    Laure Kaluzinski
    Caroline Petorin
    Benoist Chibaudel
    Thomas Aparicio
    Anaïs Bodere
    Yves Rinaldi
    Karine Le Malicot
    Jean-François Emile
    Côme Lepage
    Aurélia Baures
    Hanane Djamai
    Valérie Taly
    Pierre Laurent-Puig
    Communications Medicine, 5 (1):
  • [45] Site specific tumor microenvironments modulate the immune checkpoint inhibitors response in models of CT26 colon carcinoma
    Zhao, Fei
    Thompson, Caitlin
    Barnes, Nicole
    Roques, Jose
    Coleman, Terrence
    Rowe, Tyler
    Kolb, Joseph
    Hall, Chassidy
    Fadden, Patrick
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Lenvatinib plus Immune Checkpoint Inhibitors versus Lenvatinib monotherapy as treatment for advanced hepatocellular carcinoma: a meta-analysis
    Yu, Xinlin
    Wei, Chun
    Cui, Ran
    Jiang, Ou
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2023, 16 (11): : 321 - 331
  • [47] TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
    Zeng, Zexian
    Wong, Cheryl J.
    Yang, Lin
    Ouardaoui, Nofal
    Li, Dian
    Zhang, Wubing
    Gu, Shengqing
    Zhang, Yi
    Liu, Yang
    Wang, Xiaoqing
    Fu, Jingxin
    Zhou, Liye
    Zhang, Boning
    Kim, Sarah
    Yates, Kathleen B.
    Brown, Myles
    Freeman, Gordon J.
    Uppaluri, Ravindra
    Manguso, Robert
    Liu, X. Shirley
    NUCLEIC ACIDS RESEARCH, 2022, 50 (D1) : D1391 - D1397
  • [48] Combination of IGF-1R targeted alpha therapy with checkpoint inhibitors results in synergistic efficacy in a syngeneic colorectal tumor model.
    Patel, Sonal
    Grinshtein, Natalie
    Simms, Ryan
    Hu, Meiduo
    Valliant, John
    Burak, Eric
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors
    Liang, Ying
    Wang, Lingling
    Ma, Peijun
    Ju, Dongen
    Zhao, Minggao
    Shi, Yun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
    Goshima, Tsubasa
    Ieguchi, Katsuaki
    Onishi, Nobuyuki
    Shimizu, Takashi
    Takayanagi, Daisuke
    Watanabe, Makoto
    Fujimoto, Yuki
    Ohkuma, Ryotaro
    Suzuki, Risako
    Tsurui, Toshiaki
    Mura, Emiko
    Iriguchi, Nana
    Ishiguro, Tomoyuki
    Shimokawa, Masahiro
    Hirasawa, Yuya
    Kubota, Yutaro
    Ariizumi, Hirotsugu
    Horiike, Atsushi
    Yoshimura, Kiyoshi
    Tsuji, Mayumi
    Kiuchi, Yuji
    Kobayashi, Shinichi
    Fujishiro, Jun
    Hoffman, Robert M.
    Tsunoda, Takuya
    Wada, Satoshi
    ANTICANCER RESEARCH, 2024, 44 (01) : 23 - 29
12345